AQR CAPITAL MANAGEMENT LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1167557
Greenwich, CT
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$306,070,117
+$229,697,940 QoQ
Shares Held
616,170
+260.3% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#48
of 1,705 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,646,694,420 across 216 Biotechnology names. VRTX ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $306,070,117 | 616,170 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $76,372,177 | 171,031 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $65,125,614 | 143,651 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $63,321,528 | 161,683 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $63,011,825 | 141,536 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $70,721,176 | 145,871 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $98,977,618 | 245,785 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $223,638,832 | 480,861 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $251,287,351 | 536,114 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $278,683,503 | 666,691 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $262,349,650 | 644,768 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $223,769,646 | 643,497 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $215,520,240 | 612,430 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $180,067,231 | 571,515 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $169,685,395 | 587,594 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $143,186,505 | 494,531 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $145,624,563 | 516,784 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $130,470,385 | 499,944 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $131,426,866 | 598,483 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $115,965,709 | 639,317 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $142,502,606 | 706,753 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $195,663,146 | 910,527 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $132,440,445 | 560,381 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $175,318,207 | 644,268 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $177,616,011 | 611,815 | Shares | Other | 2020-08-17 | |
| 2020-03-31 | $141,549,314 | 594,870 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||